These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9063746)

  • 1. UFD1L, a developmentally expressed ubiquitination gene, is deleted in CATCH 22 syndrome.
    Pizzuti A; Novelli G; Ratti A; Amati F; Mari A; Calabrese G; Nicolis S; Silani V; Marino B; Scarlato G; Ottolenghi S; Dallapiccola B
    Hum Mol Genet; 1997 Feb; 6(2):259-65. PubMed ID: 9063746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning and characterization of the gene encoding human NPL4, a protein interacting with the ubiquitin fusion-degradation protein (UFD1L).
    Botta A; Tandoi C; Fini G; Calabrese G; Dallapiccola B; Novelli G
    Gene; 2001 Sep; 275(1):39-46. PubMed ID: 11574150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of a novel gene containing WD40 repeats from the region deleted in velo-cardio-facial/DiGeorge syndrome on chromosome 22q11.
    Funke B; Pandita RK; Morrow BE
    Genomics; 2001 May; 73(3):264-71. PubMed ID: 11350118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of a human gene containing a nuclear localization signal from the critical region for velo-cardio-facial syndrome on 22q11.
    Funke B; Puech A; Saint-Jore B; Pandita R; Skoultchi A; Morrow B
    Genomics; 1998 Oct; 53(2):146-54. PubMed ID: 9790763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of a novel gene from the DiGeorge chromosomal region that encodes for a mediator subunit.
    Berti L; Mittler G; Przemeck GK; Stelzer G; Günzler B; Amati F; Conti E; Dallapiccola B; Hrabé de Angelis M; Novelli G; Meisterernst M
    Genomics; 2001 Jun; 74(3):320-32. PubMed ID: 11414760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of a gene expressed during early embryogenesis from the region of 22q11 commonly deleted in DiGeorge syndrome.
    Halford S; Wilson DI; Daw SC; Roberts C; Wadey R; Kamath S; Wickremasinghe A; Burn J; Goodship J; Mattei MG
    Hum Mol Genet; 1993 Oct; 2(10):1577-82. PubMed ID: 8268909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification, characterization, and precise mapping of a human gene encoding a novel membrane-spanning protein from the 22q11 region deleted in velo-cardio-facial syndrome.
    Sirotkin H; Morrow B; Saint-Jore B; Puech A; Das Gupta R; Patanjali SR; Skoultchi A; Weissman SM; Kucherlapati R
    Genomics; 1997 Jun; 42(2):245-51. PubMed ID: 9192844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a new human catenin gene family member (ARVCF) from the region deleted in velo-cardio-facial syndrome.
    Sirotkin H; O'Donnell H; DasGupta R; Halford S; St Jore B; Puech A; Parimoo S; Morrow B; Skoultchi A; Weissman SM; Scambler P; Kucherlapati R
    Genomics; 1997 Apr; 41(1):75-83. PubMed ID: 9126485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and mutation analysis of goosecoid-like (GSCL), a homeodomain-containing gene that maps to the critical region for VCFS/DGS on 22q11.
    Funke B; Saint-Jore B; Puech A; Sirotkin H; Edelmann L; Carlson C; Raft S; Pandita RK; Kucherlapati R; Skoultchi A; Morrow BE
    Genomics; 1997 Dec; 46(3):364-72. PubMed ID: 9441739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of a new clathrin heavy chain gene with muscle-specific expression from the region commonly deleted in velo-cardio-facial syndrome.
    Sirotkin H; Morrow B; DasGupta R; Goldberg R; Patanjali SR; Shi G; Cannizzaro L; Shprintzen R; Weissman SM; Kucherlapati R
    Hum Mol Genet; 1996 May; 5(5):617-24. PubMed ID: 8733128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mice overexpressing genes from the 22q11 region deleted in velo-cardio-facial syndrome/DiGeorge syndrome have middle and inner ear defects.
    Funke B; Epstein JA; Kochilas LK; Lu MM; Pandita RK; Liao J; Bauerndistel R; Schüler T; Schorle H; Brown MC; Adams J; Morrow BE
    Hum Mol Genet; 2001 Oct; 10(22):2549-56. PubMed ID: 11709542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and expression of the human ubiquitin fusion-degradation gene (UFD1L).
    Novelli G; Mari A; Amati F; Colosimo A; Sangiuolo F; Bengala M; Conti E; Ratti A; Bordoni R; Pizzuti A; Baldini A; Crinelli R; Pandolfi F; Magnani M; Dallapiccola B
    Biochim Biophys Acta; 1998 Mar; 1396(2):158-62. PubMed ID: 9540831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning and characterization of a novel human ubiquitin-specific protease, a homologue of murine UBP43 (Usp18).
    Schwer H; Liu LQ; Zhou L; Little MT; Pan Z; Hetherington CJ; Zhang DE
    Genomics; 2000 Apr; 65(1):44-52. PubMed ID: 10777664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA fluorescent probes for diagnosis of velocardiofacial and related syndromes.
    Crifasi PA; Michels VV; Driscoll DJ; Jalal SM; Dewald GW
    Mayo Clin Proc; 1995 Dec; 70(12):1148-53. PubMed ID: 7490915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CATCH 22 syndrome: report of 7 infants with follow-up data and review of the recent advancements in the genetic knowledge of the locus 22q11.
    Sergi C; Serpi M; Müller-Navia J; Schnabel PA; Hagl S; Otto HF; Ulmer HE
    Pathologica; 1999 Jun; 91(3):166-72. PubMed ID: 10536461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A common region of 10p deleted in DiGeorge and velocardiofacial syndromes.
    Daw SC; Taylor C; Kraman M; Call K; Mao J; Schuffenhauer S; Meitinger T; Lipson T; Goodship J; Scambler P
    Nat Genet; 1996 Aug; 13(4):458-60. PubMed ID: 8696341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 22q11.2 deletion: from diversity to a single gene theory.
    De Decker HP; Lawrenson JB
    Genet Med; 2001; 3(1):2-5. PubMed ID: 11339372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positional mapping of loci in the DiGeorge critical region at chromosome 22q11 using a new marker (D22S183).
    Mulder MP; Wilke M; Langeveld A; Wilming LG; Hagemeijer A; van Drunen E; Zwarthoff EC; Riegman PH; Deelen WH; van den Ouweland AM
    Hum Genet; 1995 Aug; 96(2):133-41. PubMed ID: 7635459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confirmation that the velo-cardio-facial syndrome is associated with haplo-insufficiency of genes at chromosome 22q11.
    Kelly D; Goldberg R; Wilson D; Lindsay E; Carey A; Goodship J; Burn J; Cross I; Shprintzen RJ; Scambler PJ
    Am J Med Genet; 1993 Feb; 45(3):308-12. PubMed ID: 8434616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CATCH 22: deletion of locus 22q11 in velocardiofacial syndrome, DiGeorge anomaly, and nonsyndromic conotruncal defects.
    Hou JW; Wang JK; Tsai WY; Chou CC; Wang TR
    J Formos Med Assoc; 1997 Jun; 96(6):419-23. PubMed ID: 9216164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.